88 related articles for article (PubMed ID: 2211008)
21. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells.
Tanaka Y; Mine S; Hanagiri T; Hiraga T; Morimoto I; Figdor CG; van Kooyk Y; Ozawa H; Nakamura T; Yasumoto K; Eto S
Cancer Res; 1998 Sep; 58(18):4138-45. PubMed ID: 9751626
[TBL] [Abstract][Full Text] [Related]
22. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.
Peterfalvi A; Gomori E; Magyarlaki T; Pal J; Banati M; Javorhazy A; Szekeres-Bartho J; Szereday L; Illes Z
Int Immunol; 2008 Dec; 20(12):1517-25. PubMed ID: 18927318
[TBL] [Abstract][Full Text] [Related]
23. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
24. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
[TBL] [Abstract][Full Text] [Related]
25. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?
Staibano S; Mascolo M; Tranfa F; Salvatore G; Mignogna C; Bufo P; Nugnes L; Bonavolontà G; De Rosa G
Int J Immunopathol Pharmacol; 2006; 19(1):171-9. PubMed ID: 16569355
[TBL] [Abstract][Full Text] [Related]
26. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
[TBL] [Abstract][Full Text] [Related]
27. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
Engleman EG; Benike CJ; Grumet FC; Evans RL
J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
[TBL] [Abstract][Full Text] [Related]
28. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
29. Infiltrating lymphocytes and antigen expression in uveal melanoma.
Meecham WJ; Char DH; Kaleta-Michaels S
Ophthalmic Res; 1992; 24(1):20-6. PubMed ID: 1608588
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cellular infiltration in choroidal melanoma.
Tobal K; Deuble K; McCartney A; Lightman S
Melanoma Res; 1993 Feb; 3(1):63-5. PubMed ID: 8471838
[TBL] [Abstract][Full Text] [Related]
31. Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.
Nagarkatti-Gude N; Bronkhorst IH; van Duinen SG; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6748-55. PubMed ID: 22930720
[TBL] [Abstract][Full Text] [Related]
32. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.
Signore A; Annovazzi A; Barone R; Bonanno E; D'Alessandria C; Chianelli M; Mather SJ; Bottoni U; Panetta C; Innocenzi D; Scopinaro F; Calvieri S
J Nucl Med; 2004 Oct; 45(10):1647-52. PubMed ID: 15471828
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients.
Whitford P; George WD; Campbell AM
Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139
[TBL] [Abstract][Full Text] [Related]
34. Analysis of clonality of tumour infiltrating lymphocytes in breast cancer and uveal melanoma.
Durie FH; George WD; Campbell AM; Damato BE
Immunol Lett; 1992 Aug; 33(3):263-9. PubMed ID: 1428001
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
Whitford P; Mallon EA; George WD; Campbell AM
Br J Cancer; 1990 Dec; 62(6):971-5. PubMed ID: 2124138
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous cell cycle and phenotypic analysis of primary uveal melanoma by flow cytometry.
Lawry J; Smith MO; Parsons MA; Rennie IG
Eye (Lond); 1998; 12 ( Pt 3a)():431-9. PubMed ID: 9775246
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte subpopulations before therapy in patients with uveal malignant melanoma.
Flynn K; Felberg NT; Koegel A; Hager R; Shields JA; Augsburger JJ; Donoso LA
Am J Ophthalmol; 1986 Feb; 101(2):160-3. PubMed ID: 3946530
[TBL] [Abstract][Full Text] [Related]
38. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
[TBL] [Abstract][Full Text] [Related]
39. Infiltrative T regulatory cells in enucleated uveal melanomas.
Lagouros E; Salomao D; Thorland E; Hodge DO; Vile R; Pulido JS
Trans Am Ophthalmol Soc; 2009 Dec; 107():223-8. PubMed ID: 20126498
[TBL] [Abstract][Full Text] [Related]
40. Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.
Ralfkiaer E; Hou-Jensen K; Gatter KC; Drzewiecki KT; Mason DY
Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):355-61. PubMed ID: 3101284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]